X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Duchenne Muscular Dystrophy Treatment Companies

This report lists the top Duchenne Muscular Dystrophy Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Duchenne Muscular Dystrophy Treatment industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Duchenne Muscular Dystrophy Treatment Market Companies

Duchenne Muscular Dystrophy Treatment Top Companies

  1. Pfizer Inc.

  2. Sarepta Therapeutics

  3. PTC Therapeutics

  4. FibroGen Inc.

  5. F. Hoffmann-La Roche AG

*Disclaimer: Top companies sorted in no particular order

Duchenne Muscular Dystrophy Treatment Market Major Players

Duchenne Muscular Dystrophy Treatment Market Concentration

Duchenne Muscular Dystrophy Treatment Market Concentration

Duchenne Muscular Dystrophy Treatment Company List

                        • BioMarin

                        • Fibrogen Inc.

                        • Nobelpharma Co. Ltd

                        • NS Pharma Inc.

                        • Pfizer Inc.

                        • PTC Therapeutics

                        • Santhera Pharmaceuticals

                        • Sarepta Therapeutics

                        • F. Hoffmann-La Roche AG

                        • ReveraGen BioPharma


                    Specific to Duchenne Muscular Dystrophy Treatment Market
                    Need More Details On Market Players And Competitors?
                    Download Sample

                    Duchenne Muscular Dystrophy Treatment Market Report Snapshots

                    Duchenne Muscular Dystrophy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)